India
Intravenous Anesthetic Market, by Type (Barbiturates, Ketamine,
Benzodiazepines, Propofol, and Others) and by End User (Hospitals, Clinics, and
Others) is estimated to be valued at US$ 65.0 million in 2019 and is expected
to exhibit a CAGR of 2.6% over the forecast period (2019-2027), as highlighted
in a new report published by Coherent Market Insights.
Intravenous anesthetics are a
group of fast-acting compounds that are used to induce complete sedation. Some
of the important intravenous anesthetics include propofol, etomidate, ketamine,
and barbiturates. The increasing number of surgeries in India is a key factor
that is expected to drive growth of the India intravenous anesthetic market
over the forecast period. Moreover, increasing number of heart disease in India
is one of the key factor that leads to rising number of different surgeries in
India. For instance, according to the CADI Research Foundation data, in 2010,
around 47 million Indians suffered from coronary artery disease (CAD). Moreover,
around 60,000 coronary bypass surgeries are performed every year in India. Such
high number of surgeries performed in India is expected to fuel growth of the
India intravenous anesthetic market.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/3558
Increasing adoption of surgical
robots made advancement in surgical procedures which is expected to fuel growth
of the India intravenous anesthetic market over the forecast period.
Advancements in surgical products and technologies have led to shift from
conventional surgeries to minimally invasive surgeries. The usage of robotic
technology conducting minimally invasive surgeries has resulted in significant
changes in surgical procedures. The acceptance of robotic surgeries increased
the number of surgeries performed in India. Moreover, these increasing surgeries
are expected to drive growth of the India intravenous anesthetic market over
the forecast period.
Browse 13 Market Data Tables and
11 figures spread through 82 pages and in-depth TOC on 'India intravenous
anesthetic market, Forecast to 2027'
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/india-intravenous-anesthetic-market-3558
Key Takeaways of the India
intravenous anesthetic market:
India intravenous anesthetic
market is expected to exhibit a CAGR of 2.6% over the forecast period
(2019-2027), owing to increasing number of surgeries performed in India
Among type, propofol segment is
expected to hold a dominant position in the India intravenous anesthetic
market, owing to high adoption of propofol by Indian healthcare professional
for anesthetic procedure
Major players operating in the
India intravenous anesthetic market include AstraZeneca Plc, Fresenius Kabi,
AbbVie Inc., Baxter International Inc., B. Braun Melsungen AG, Maruishi
Pharmaceutical Co., Ltd, Piramal Healthcare, Hikma Pharmaceuticals, and Mylan
N.V.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/3558
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment